CDT Equity Inc. SEC filings CDTTW

CDT Equity Inc. has 368 filings in SEC EDGAR's recent list, going back to Dec 9, 2021. Its latest annual report, Form ARS, was filed on Aug 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on December 31.

CDT Equity Inc. SEC filings
Form Description Filed Period
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Nov 4, 2026 Nov 2, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 27, 2026 Oct 22, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Oct 13, 2026 Oct 6, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Sep 25, 2026 Sep 24, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 18, 2026 Sep 14, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 4, 2026 Aug 31, 2026
8-K Current report
Other events
Sep 1, 2026 Aug 28, 2026
8-K Current report
Officer or director change, Shareholder vote results
Sep 1, 2026 Aug 28, 2026
8-K/A Amended current report Aug 21, 2026 Jul 30, 2026
8-K/A Amended current report
Acquisition or sale of assets
Aug 21, 2026 Feb 19, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Aug 6, 2026 Jul 31, 2026
8-K/A Amended current report
Acquisition or sale of assets
Aug 3, 2026 Jul 30, 2026
8-K Current report
Material agreement, Unregistered share sale
Jul 31, 2026 Jul 30, 2026
8-K Current report
Unregistered share sale
Jul 29, 2026 Jul 24, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jul 16, 2026 Jul 15, 2026
8-K Current report
Material agreement, New debt
Jul 7, 2026 Jun 30, 2026
8-K Current report
Auditor change
Jun 29, 2026 Jun 23, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jun 16, 2026 Jun 11, 2026
8-K Current report
Listing notice, Regulation FD disclosure
May 28, 2026 May 21, 2026
8-K Current report
Material agreement
May 15, 2026 May 15, 2026
8-K Current report
Officer or director change
Apr 27, 2026 Apr 27, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Mar 25, 2026 Mar 24, 2026
8-K Current report
Shareholder vote results
Mar 18, 2026 Mar 17, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale
Mar 9, 2026 Mar 3, 2026
8-K Current report
Material agreement, Unregistered share sale
Feb 24, 2026 Feb 19, 2026
8-K Current report
Material agreement, Unregistered share sale
Jan 22, 2026 Jan 16, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 2, 2026 Dec 28, 2025
8-K Current report
Material agreement, Unregistered share sale
Dec 12, 2025 Dec 8, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Oct 9, 2025 Oct 8, 2025
8-K Current report
Restatement
Aug 14, 2025 Aug 8, 2025
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
Aug 8, 2025 Aug 4, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jun 9, 2025 Jun 3, 2025
8-K Current report Jun 3, 2025 Jun 3, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
May 16, 2025 May 15, 2025
8-K Current report
Shareholder vote results
May 6, 2025 May 5, 2025
8-K Current report
Auditor change
Apr 25, 2025 Apr 24, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 16, 2025 Apr 12, 2025
8-K Current report
Material agreement, Unregistered share sale
Apr 4, 2025 Mar 31, 2025
8-K/A Amended current report
Other events
Apr 2, 2025 Mar 31, 2025
8-K Current report
Other events
Apr 1, 2025 Mar 31, 2025
8-K Current report
Other events
Mar 6, 2025 Mar 5, 2025
8-K Current report
Agreement ended, Listing notice, Other events
Feb 19, 2025 Feb 12, 2025
8-K Current report
Other events
Feb 11, 2025 Feb 7, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jan 23, 2025 Jan 22, 2025
8-K Current report
Shareholder vote results
Jan 14, 2025 Jan 13, 2025
8-K Current report
Listing notice, Shareholder vote results
Dec 20, 2024 Dec 17, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Dec 17, 2024 Dec 12, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale
Nov 25, 2024 Nov 22, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change
Nov 19, 2024 Nov 14, 2024
8-K Current report
Restatement
Nov 14, 2024 Nov 12, 2024
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
Nov 1, 2024 Oct 28, 2024
8-K Current report
Material agreement, New debt
Oct 15, 2024 Oct 9, 2024
8-K Current report Sep 6, 2024 Sep 6, 2024
8-K Current report
Listing notice, Other events
Aug 16, 2024 Aug 15, 2024
8-K Current report
Material agreement, Unregistered share sale
Aug 8, 2024 Aug 7, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale
Aug 7, 2024 Aug 6, 2024
8-K/A Amended current report Jul 11, 2024 Jul 1, 2024
8-K Current report Jul 1, 2024 Jul 1, 2024
8-K Current report
Listing notice
May 31, 2024 May 28, 2024
8-K Current report
Restatement
Apr 16, 2024 Apr 11, 2024
8-K/A Amended current report
Material agreement, Acquisition or sale of assets, Listing notice, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Oct 5, 2023 Sep 22, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, Listing notice, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Sep 29, 2023 Sep 22, 2023
8-K Current report
Shareholder vote results, Other events
Sep 21, 2023 Sep 20, 2023
8-K Current report
Material agreement, Other events
Sep 13, 2023 Sep 13, 2023
8-K Current report
Other events
Sep 7, 2023 Sep 7, 2023
8-K Current report
Other events
Aug 31, 2023 Aug 31, 2023
8-K Current report
Other events
Aug 23, 2023 Aug 23, 2023
8-K Current report
Other events
Aug 16, 2023 Aug 16, 2023
8-K Current report
Regulation FD disclosure
Jul 21, 2023 Jul 21, 2023
8-K Current report
Material agreement
May 11, 2023 May 11, 2023
8-K Current report
Listing notice
Apr 14, 2023 Apr 10, 2023
8-K Current report
Material agreement, New debt
Mar 8, 2023 Mar 7, 2023
8-K Current report
Bylaw or fiscal year change, Other events
Feb 3, 2023 Feb 2, 2023
8-K Current report
Shareholder vote results
Feb 1, 2023 Jan 26, 2023
8-K Current report
Material agreement
Jan 30, 2023 Jan 27, 2023
8-K Current report
Material agreement, Unregistered share sale
Nov 14, 2022 Nov 8, 2022
8-K Current report
Regulation FD disclosure
Nov 8, 2022 Nov 8, 2022
8-K Current report
Other events
Mar 28, 2022 Mar 28, 2022
8-K Current report
Other events
Feb 14, 2022 Feb 2, 2022
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Feb 8, 2022 Feb 2, 2022

Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CDT (Nasdaq), CDTTW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Naples, FL
SEC filer status
, Emerging growth company
SEC CIK
1896212
Former names
CONDUIT PHARMACEUTICALS INC. (until Aug 7, 2025); Murphy Canyon Acquisition Corp. (until Sep 21, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.